Previous Article | Next Article ![]()
Infection and Immunity, February 2007, p. 565-573, Vol. 75, No. 2
0019-9567/07/$08.00+0 doi:10.1128/IAI.01479-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
,
Department of Molecular Bacteriology, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita-city, Osaka 565-0871, Japan,1 Laboratory of Bacterial Infection, Kitasato Institute for Life Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8642, Japan2
Received 15 September 2006/ Returned for modification 4 November 2006/ Accepted 14 November 2006
|
|
|---|
|
|
|---|
In the course of analyzing the pathogenesis of EPEC, we found that the bacteria recruit zonula occludens-1 (ZO-1) to the actin-rich structures that they have created. It is well known that ZO-1 generally concentrates at intercellular tight junctions and is not accumulated in other actin-rich structures such as stress fibers and filopodia. This implies that ZO-1 may play a role in the production, maintenance, or other functions of the bacterium-created actin-rich structures. In this study, we describe the mechanism by which ZO-1 is recruited in the pedestal produced by EPEC and that a similar recruitment is observed with S. flexneri and L. monocytogenes. Results presented here indicate that three pathogenic bacteria, EPEC, Shigella, and Listeria, recruited ZO-1 to the actin-rich structures through a similar mechanism. We propose that certain pathogenic bacteria create particular actin-rich structures that attract ZO-1 through a signal generated by WASP-related molecules.
|
|
|---|
Guk were constructed by amplification of the respective DNA fragments by PCR using pEGFP/CZO-1 as a template and cloning the fragments into the KpnI-EcoRI site of pcDNA3mEGFP-C. The PCR primers used for each construct are as follows: for CZO-1
SH3,
SH3-F and
SH3-R; for CZO-1
PRR,
PRR-F and
PRR-R; and for CZO-1PRR, PRR-F and PRR-R. The plasmid pEGFP/CZO-1
Guk used for the expression of CZO-1
Guk was constructed by amplifying the DNA fragment (encoding amino acids 507 to 591 of ZO-1) by PCR with primers
Guk-F and
Guk-R and cloning it into the KpnI-HindIII site of pEGFP/CZO-1. The DNA fragment encoding the N terminus of ZO-1 (NZO-1; encompassing amino acids 1 to 506) tagged with a vesicular stomatitis virus glycoprotein (VSVG) epitope at its C terminus was amplified using a template cDNA of mouse ZO-1 with the primers NZO-F and NZO-R and cloned into the KpnI-EcoRI site of pcDNA3. DNA constructs encoding fused forms of CD16/7 with Nck SH3 domains and control plasmids were kindly provided by Bruce J. Mayer, University of Connecticut Health Center. The plasmid p99-tir for the expression of a wild-type Tir in tir -deficient mutant was described in a previous study (36). p99-tirY474F, a plasmid for the expression of a mutant Tir (Y474F), was generated from p99-tir using a Quick Change site-directed mutagenesis kit (Strategene) with the primers TirY474/F and TirY474/R. |
View this table: [in a new window] |
TABLE 1. Primers used in this study
|
For transfection experiments, HeLa and NIH 3T3 cells were plated on a coverslip (13 mm in diameter) in a 24-well plate at a density of 5 x 104 cells/well. After 18 to 20 h, plasmid DNA (400 ng) was transfected to the cells using Lipofectamine-Plus reagent (Invitrogen) by the method recommended by the manufacturer. The cells were incubated in DMEM-15% FBS for 21 h and infected with EPEC or treated with anti-CD16 antibody, as described below.
Bacterial strains and infection experiments. E2348/69 (O127:K63:H6) is a wild-type strain of EPEC originally isolated from an epidemic case in England (27). Mutant strains were prepared from E2348/69 and have been reported elsewhere (33). Shigella flexneri 2a strain 15H405 and Listeria monocytogenes RIMD1205001 were obtained from the Osaka Prefectural Institute of Public Health and the International Research Center for Infectious Diseases, Pathogenic Microbes Repository Unit, Osaka University, respectively.
EPEC and the mutants were precultured at 37°C overnight in LB broth. S. flexneri cells were precultured at 37°C overnight in tryptose phosphate broth (Difco). Aliquots (120 µl) of the precultures were inoculated into 3 ml of DMEM and incubated for 3 h at 37°C in a CO2 incubator. The bacterial suspensions were diluted with DMEM and subjected to infection experiments. L. monocytogenes precultured in brain heart infusion broth (Difco) at 37°C overnight were washed with 10 mM phosphate-buffered saline (PBS), pH 7.0, and promptly resuspended in DMEM for infection experiments as described below.
For the infection by EPEC, Caco/B7 cells were seeded on a polyester membrane support (Transwell Clear; Corning) in a 24-well plate at a density of 4.5 x 104 cells/well (0.33 cm2) and incubated for 5 days. HeLa cells (0.8 x 105 to 1.0 x 105 cells/well) were plated on a coverglass (13-mm diameter) in a 24-well plate at 37°C overnight. The cells were infected with EPEC at a multiplicity of infection (MOI) of 15 to 20 for 1 h in a CO2 incubator. Nonadherent bacteria were washed with prewarmed DMEM, and the cells were incubated at 37°C thereafter. When HeLa cells were infected, the incubation was paused at 2 h, and additional incubation for 3 h was performed to promote pedestal elongation in the presence of gentamicin at a final concentration of 100 µg/ml.
For the infection by S. flexneri or L. monocytogenes, HeLa cells (0.8 x 105 to 1.0 x 105 cells/well) on a coverglass dipped in a 24-well plate with serum-free DMEM were infected with bacteria at MOIs of 100 for S. flexneri and 50 to 80 for L. monocytogenes. The culture plates were centrifuged at 700 x g for 10 min at room temperature to enhance bacterial contact with the host cells. After 30 min at 37°C, the plates were washed three times and then incubated in DMEM-10% FBS containing 100 µg/ml gentamicin for 2 to 3 h (S. flexneri) or 3 to 4 h (L. monocytogenes) at 37°C in a CO2 incubator.
Induction of artificial Tir-intimin interaction by intimin-coated latex beads.
Recombinant glutathione S -transferase (GST) and GST-intimin were prepared as described previously (36). Latex beads (Sekisui Chemical Co., Ltd.; average diameter, 0.993 µm) suspended in PBS at a concentration of 2 x 1010 beads/ml were mixed with an equal volume of 100 µg/ml of purified recombinant GST or GST-intimin and incubated for 80 min at 4°C. The beads were then incubated in PBS-0.1% bovine serum albumin (BSA) for 60 min at 4°C, washed with PBS three times, and suspended in 0.5 ml of PBS-BSA at a final density of 4.0 x 109 beads/ml. Monolayers of Caco/B7 cells on Transwells were preinfected with an intimin-deficient mutant of EPEC (
eae) at an MOI of 100 and incubated for 1 h at 37°C in a CO2 incubator. After the incubation, nonadherent bacteria were removed by gentle washing with DMEM three times. The cells were treated with the intimin-coated beads at a ratio of 400 beads per cell at 37°C in a CO2 incubator. The treated cells were fixed and stained for ZO-1 and F-actin, as described below. The number of ZO-1- or F-actin-positive beads was counted under a microscope and is represented as a percentage of the total number of beads in the field.
Antibody-mediated clustering of membrane-targeted Nck SH3 domains (Nck clustering assay). Clustering of membrane-targeted Nck SH3 domains was performed by antibody-mediated cross-linking of forms of CD16/7 fused with Nck SH3 domains as described previously (44). NIH 3T3 cells expressing the fusion proteins were incubated with a rat monoclonal antibody against human CD16 in DMEM-10% FBS for 1 h at 37°C. After being washed with prewarmed serum-free DMEM three times, the cells were reacted with Alexa 546-conjugated anti-rat immunoglobulin G (IgG) in DMEM-10% FBS for an additional hour at 37°C. The cells were fixed and stained with Alexa 488-phalloidin, T8-754, and Alexa 488-conjugated anti-mouse IgG antibody, as described below.
Immunofluorescence microscopy. The cells on the filter support or the coverglass were washed three times with DMEM and fixed with 4% paraformaldehyde in PBS for 20 min at room temperature. After permeabilization with 0.1% Triton X-100 in PBS for 10 min, the cells were incubated with PBS(+)-BSA (PBS containing 0.1%BSA, 2 mM CaCl2, and 0.5 mM MgCl2) for 10 min and then with the primary antibodies diluted with PBS(+)-BSA for 60 min at room temperature. After being washed with PBS, the samples were allowed to react with the secondary antibodies diluted with PBS(+)-BSA for 60 min at room temperature together with rhodamine-phalloidin (Invitrogen) to stain F-actin. When necessary, bacteria and cell nuclei were stained with 4',6'-diamidino-2-phenylindole (DAPI; Invitrogen). The rabbit anti-intimin antibody was prepared as described previously (36). Anti-ZO-1 mouse monoclonal antibody (T8-754) was a gift from Sho-ichiro Tsukita, Kyoto University. The antiphosphotyrosine monoclonal antibody 4G10 was purchased from Upstate, Inc. Anti-O127 rabbit serum was from Denka Seiken Co., Ltd. The secondary antibodies conjugated with Alexa 350, Alexa 488, or Alexa 546 were purchased from Invitrogen.
The expression of NZO-1 was detected by immunostaining with anti-VSVG goat antibody (Abcam, Inc.) and anti-goat IgG conjugated with Alexa 488. The expression of CZO-1 and its truncated forms was detected by the fluorescence of mEGFP. The expression and aggregation of CD16/7 fusion proteins were detected with anti-human CD16 rat antibody (Serotec, Ltd.) and anti-rat IgG conjugated with Alexa 546.
The immunostained samples were mounted in Perma Fluor aqueous mounting medium (Shandon/Lipshaw, Pittsburgh, PA) and observed with an epifluorescence microscope (model BX50; Olympus). Images were collected and analyzed with Photometrics Cool SNAP HQ (Roper Scientific) and Photoshop (Adobe).
|
|
|---|
escC mutant and a
espA mutant (39). Infection of Caco/B7 monolayers by either mutant failed to induce the recruitment (Fig. 1D) (data not shown), indicating that "effectors" secreted through TTSS (24) mediate the recruitment. We then focused on an effector, Tir, and an outer membrane adhesin, intimin, because these are the inducers of the localized cytoskeletal reorganization beneath the adhered bacteria (7, 28). As a result, neither a tir-deficient (
tir) mutant nor the
eae mutant triggered recruitment of ZO-1 (Fig. 1D). A control espF-deficient strain that is partially defective in barrier-disrupting activity, but is able to induce actin polymerization (34), did induce the recruitment, as the wild-type EPEC did (data not shown). The expression of the respective gene in the
tir or
eae mutant from plasmids restored the ability to recruit ZO-1 (data not shown). These results collectively suggest the importance of the binding of Tir with intimin for the recruitment of ZO-1.
![]() View larger version (54K): [in a new window] |
FIG. 1. EPEC recruits ZO-1 to site of the bacterial attachment and to the distal part of the pedestal body. (A) Time course of changes in the localization of ZO-1 in Caco/B7 monolayers infected by EPEC. An uninfected monolayer and monolayers infected with EPEC for 3 h, 5 h, or 9 h were fixed and stained for ZO-1 as described in Materials and Methods. It is notable that the infection caused an irregular and discontinuous ZO-1 staining at intercellular junctions. Scale bar, 20 µm. (B) A higher magnification of the region boxed in white lines in panel A (3hr). ZO-1 was stained with anti-ZO-1 antibody (left panel, red), and wild-type EPEC was stained with anti-intimin polyclonal antibody (center panel, green). A composite image is shown on the right. Scale bar, 5 µm. (C) ZO-1's recruitment to the bacterial attachment sites. Cells infected with EPEC for 3 h were fixed and subjected to immunostaining with different fluorescein reagents as follows. EPEC was stained with anti-intimin antibody (two panels on the left; green) or with DAPI (two panels on the right; blue). ZO-1 was first labeled with T8-754 and visualized with Alexa 546-conjugated secondary antibody (two panels on the left; red) or with Alexa 488-conjugated secondary antibody (two panels on the right; green). Scale bar, 3 µm. (D) TTSS, Tir, and intimin are required for the EPEC-induced recruitment of ZO-1. Caco/B7 monolayers cultured on filter supports were infected with EPEC wild-type (WT) or mutant strains for 3 h. The cells were fixed and stained for ZO-1 with anti-ZO-1 antibody (green) and for F-actin with rhodamine-phalloidin (red). The bacteria adhered on the cells were stained either with anti-intimin antibody (wild type and escC and tir mutants) or with anti-O127 antiserum ( eae mutant) and visualized with Alexa 350-conjugated anti-rabbit IgG antibody (blue). Scale bar, 5 µm. (E) Binding of intimin-coated beads to the translocated Tir on the cell surface induces actin polymerization and the recruitment of ZO-1. Caco/B7 monolayers were primed by infection with eae mutant for 1 h. Then the monolayers were washed and challenged with latex beads coated with GST-intimin fusion protein. The monolayers were subjected to staining for ZO-1 and F-actin with anti-ZO-1 antibody (green) and rhodamine-phalloidin (red), respectively, at 7 h postchallenge. Latex beads were detected under a phase-contrast microscope. Scale bar, 5 µm. (F) Quantitative analysis of actin condensation and recruitment of ZO-1, induced at the intimin-coated beads. The open bar represents the percentage of beads showing actin condensation, and the filled bar represents the percentage of those showing ZO-1 recruitment. Ten microscopic fields were randomly selected for the quantification per sample, and a total of 60 to 200 beads were counted per field. Data represent the means (± standard deviation) from three independent experiments. (G) Localization of ZO-1 within the pedestals produced in HeLa cells infected by wild-type EPEC. It is notable that ZO-1 (green) is accumulated in the distal part of the pedestals and is excluded from the area proximate to the attached bacterium. F-actin is stained with rhodamine-phalloidin (red), and the bacteria were stained with rabbit anti-intimin serum and Alexa 350-conjigated anti-rabbit IgG antibody (blue). Bars, 1 µm.
|
eae mutant (priming) and thereafter allowed to react with latex beads coated with recombinant intimin (challenge). Figure 1E shows the intimin bead-induced actin polymerization and ZO-1 recruitment, which indicates that the clustering of the Tir-intimin complex on artificial particles is sufficient for ZO-1's recruitment. It was noted that the beads stained positive for F-actin [F-actin(+)] were not necessarily colocalized with ZO-1, although all the beads stained positive for ZO-1 were colocalized with F-actin [F-actin(+)/ZO-1(+)]. Quantification revealed that 46.7% of the attached beads were F-actin(+), whereas only 8.5% were F-actin(+)/ZO-1(+), at 3 h postinfection (Fig. 1F). These ratios increased with time, reaching 78.8% for F-actin(+) and 55.5% for F-actin(+)/ZO-1(+) beads, at 7 h postinfection. A control that had adsorbed GST rarely adhered to the
eae mutant-primed monolayer and caused no localized actin polymerization (data not shown). ZO-1 is incorporated within the pedestal, showing a distinctive distribution pattern. The results shown in Fig. 1F suggest that ZO-1 is associated with the preformed actin-rich pedestals. We next investigated the topology of ZO-1 within the pedestals. HeLa cells were used for these experiments, because 1- to 5-µm-long projections over plasma membranes develop at a high efficiency with this cell line (16). Visualization of ZO-1 in the membranous protrusions revealed that the protein is incorporated within the pedestal body (Fig. 1G). It should be noted that ZO-1 accumulated most in the distal part of the structure and was only faintly stained in the proximal part.
To confirm if the F-actin bundles are indeed necessary for the recruitment, we used a mutant, Tir(Y474F), in which tyrosine at position 474 is replaced by phenylalanine. Previous investigations revealed that binding of intimin with Tir results in the phosphorylation of Y474 (26) and that the phosphorylation is required for the recruitment and clustering of the host adaptor protein Nck beneath the attached bacterium and for the subsequent activation of the N-WASP-Arp2/3 pathway (19, 23). As a result, neither ZO-1 accumulation nor actin polymerization was observed with the
tir mutant expressing Tir(Y474F), whereas the
tir mutant expressing a wild-type Tir caused both the accumulation and the formation of pedestals (see Fig. S1A and B in the supplemental material). The results demonstrate the necessity of the phosphorylation-dependent formation of pedestals for the recruitment of ZO-1.
The recruitment of ZO-1 is not involved in the EPEC-induced disruption of the epithelial barrier.
Amieva and colleagues have reported that Helicobacter pylori causes a similar recruitment of ZO-1 to the bacterial attachment sites in Madin-Darby canine kidney (MDCK) cell monolayers and proposed that the recruitment is linked to a dysfunctional paracellular seal (1). Because EPEC has been reported to affect the integrity of the epithelial barrier (11, 32, 34, 36, 37, 43, 54), we examined if the EPEC-induced recruitment of ZO-1 is also linked with the disruption of the barrier. A polarized Caco/B7 monolayer was infected with wild-type EPEC and the mutants, and the TER across the monolayer, which is a hallmark of the integrity of the epithelial barrier, was measured. As reported previously (36), the wild-type EPEC induced a decrease of TER, whereas the
tir strain did not (see Fig. S1C in the supplemental material). The expression of a wild-type Tir in the
tir mutant restored the barrier-disrupting ability. Notably, the expression of a mutant Tir(Y474F) in
tir also restored the ability (see Fig. S1C in the supplemental material); nevertheless, the strain does not induce ZO-1's recruitment (see Fig. S1A and B in the supplemental material). The results demonstrate that the process for the recruitment is not linked with the EPEC-induced disruption of the epithelial barrier.
The PRR of ZO-1 mediates the recruitment to the pedestals. ZO-1 is a member of the membrane-associated guanylate kinase homologue family (15, 55), and possesses three PDZ domains, an SH3 domain, a noncatalytic guanylate kinase (Guk) homology domain, an acidic domain and a basic domain, and a proline-rich C terminus (15) (Fig. 2A). To understand the functional implications of ZO-1's recruitment, we dissected ZO-1's structure and tried to identify the region involved in the recruitment process. First, the ZO-1 molecule was divided into two fragments, NZO-1 and CZO-1, at an immediate C terminus of the third PDZ domain (Fig. 2A). When expressed in HeLa cells, NZO-1 showed a diffuse distribution within the cytoplasm. Even after the cells were infected by the wild-type EPEC, no accumulation of this protein within the pedestals was observed (Fig. 2B). In contrast, CZO-1 was recruited and concentrated within the pedestals induced to form by EPEC (Fig. 2C). Truncation of the SH3 or Guk domain in CZO-1 did not affect the pattern of distribution (Fig. 2D and E), indicating that these domains are dispensable for the recruitment. On the other hand, truncation of the proline-rich region (PRR; amino acids 762 to 1746) abolished the ability of CZO-1 to be recruited to the pedestals (Fig. 2F). Also, the region alone accumulated within the pedestals (Fig. 2G), suggesting that the recruitment of ZO-1 to the pedestals was mediated by the proline-rich region.
![]() View larger version (44K): [in a new window] |
FIG. 2. Recruitment of ZO-1 to the actin-rich structures induced by three pathogens is mediated through the PRR of ZO-1 and is triggered by a WASP-related signal. (A) Schematic representation of the entire ZO-1 and the truncated forms of ZO-1 used in this study. A ZO-1 mutant with the N-terminal half (NZO-1) was tagged at the C terminus with a VSVG epitope (black box). The other mutants with the C-terminal half of ZO-1 (CZO-1, SH3, Guk, PRR, and PRR) were fused to mEGFP at their N termini (yellow box). The numbers in each box represent the positions of amino acids corresponding to the entire mouse ZO-1 sequence. (B to H) HeLa cells expressing exogenous ZO-1 mutants were infected with wild-type EPEC for 3 h. After treatment with gentamicin (100 µg/ml) for 3 h, the cells were fixed and stained for F-actin with rhodamine-phalloidin (red) and for the bacteria with anti-intimin antibody and Alexa 350-anti-rabbit IgG (blue). The expression of the ZO-1 mutant was detected with anti-VSVG tag antibody (NZO-1, panel B) or the green fluorescence of mEGFP (C to H). For a control, the cells transfected with control vector (pcDNA3mEGFP-C) are also shown (H). Scale bar, 10 µm. (I) ZO-1 is recruited to the actin comets created by S. flexneri and L. monocytogenes. HeLa cells were infected by either S. flexneri or L. monocytogenes as described in Materials and Methods. The cells were fixed and stained for endogenous ZO-1 (green) and for F-actin (red). The infected bacteria were visualized with DAPI (blue). Scale bars, 5 µm. (J) The PRR of ZO-1 mediates the recruitment of ZO-1 to the actin comets generated by S. flexneri and L. monocytogenes. HeLa cells expressing mEGFP-PRR were infected with S. flexneri (upper panel) or L. monocytogenes (lower panel) as described in Materials and Methods. Cells were fixed and stained for F-actin with rhodamine-phalloidin (red) and for the infected bacteria with DAPI (blue). Scale bar, 5 µm. (K) Clustering of the membrane-targeted Nck SH3 domains induces the recruitment of ZO-1 and formation of actin tails. NIH 3T3 cells expressing either Nck SH3(3) or Nck SH3(1+2+3) were treated with anti-CD16 and Alexa 546-conjugated anti-rat IgG antibodies. After fixation, the clustered fusion proteins were visualized (red). F-actin and ZO-1 were visualized with Alexa 488-phalloidin (upper panel, green) and anti-ZO-1 antibody (lower panel, green).
|
Nck clustering is sufficient to trigger actin polymerization and ZO-1 recruitment. A common feature among the processes of actin polymerization induced by the three bacteria is the activation of the N-WASP-related proteins and subsequent activation of the Arp2/3 complex (18). To examine if this common signal is a trigger for ZO-1's recruitment, we used an Nck clustering assay. The assay uses the three tandem SH3 domains of Nck, expressed as a chimera fused with the extracellular and transmembrane domains of the human immunoglobulin Fc receptors CD16 and CD7, respectively. Treatment of the cells expressing this chimera [Nck SH3(1+2+3)] with anti-CD16 rat antibody and anti-rat IgG antibody induces clustering of Nck SH3(1+2+3) at the cytoplasmic face of the plasma membrane, thereby triggering actin polymerization through N-WASP's activation. On the other hand, treatment of the cells expressing a control chimera, Nck SH3(3), that lacks two N-terminal SH3 domains but possesses a single SH3(3) domain, does not activate the signal (44). We caused NIH 3T3 cells to express the chimeric proteins and treated them with clustering-inducing antibodies. The treatment induced the clustering of the fusion protein and the formation of green actin tails extending from the clusters (Fig. 2K, upper panel), whereas the treatment of the cells expressing the control chimera with the antibodies did not (see Fig. S3A in the supplemental material). Next, we similarly treated the cells and stained them with anti-ZO-1 antibody, T8-754. Tail-like structures that were morphologically indistinguishable from the actin tails were observed with the cells expressing Nck SH3(1+2+3) (Fig. 2K, lower panel). In contrast, control cells expressing SH3(3) did not have "ZO-1 tails" created by the clustering-inducing antibodies (see Fig. S3B in the supplemental material). The results indicate that the clustering of Nck SH3 domains sufficiently induces localized actin polymerization and subsequent recruitment of ZO-1 and that this process requires no EPEC factors once Nck is clustered within a distinct region.
|
|
|---|
The significance of the recruitment to the bacterial pathogenesis was examined, focusing on the EPEC-induced disruption of the epithelial barrier. It turned out that the disruption was unrelated to the recruitment. The implications for other pathological effects of the bacteria are currently under investigation, using ZO-1-deficient mutant cultured mouse epithelial cells (57). Preliminary results revealed that the incidence and the morphology of the pedestals and the motility of Shigella in the cells are not significantly altered in the mutant cells (our unpublished observations). We speculate that this is due to the functional redundancy between ZO-1 and ZO-2, another member of the membrane-associated guanylate kinase homologue family (15). The speculation is strongly supported by a recent report describing that in the absence of ZO-1, some physiological functions of ZO-1 are compensated for by ZO-2 in the polarized epithelial cells (56). We confirmed that ZO-2 is expressed in Caco/B7 and HeLa cells and is also recruited to the pedestals and the actin tails (our unpublished observation). The study to clarify the biological significance of the recruitment using the cells lacking the expression of both ZO-1 and ZO-2 (56) is now in progress.
To our knowledge, we have shown for the first time that ZO-1 is recruited to the pathogen-created actin-rich structures. ZO-1 generally concentrates at tight junctions or spot-like adherens junctions (21, 22, 50) or in the nucleus of dividing cells (17). It is not usually accumulated within other actin-rich structures such as stress fibers and filopodia. The reason why ZO-1 is concentrated only within particular cytoskeletal structures like junctional complexes currently remains obscure. Therefore, understanding the mechanism of ZO-1's recruitment is of great interest in terms of cell biology. One approach to understanding this mechanism would be to identify the molecule directly bound with ZO-1. In this study, we demonstrated that the proline-rich region is responsible for the recruitment. It has been reported that within the region, ZO-1 possesses an F-actin-binding site (ABS; amino acids 1157 to 1371) (13). This had raised the possibility that ABS is involved in the recruitment of ZO-1. The possibility, however, was considered unlikely, since a truncated form of CZO-1, which lacks an entire ABS, still accumulated in the EPEC-induced pedestals (our unpublished observation). We speculate that the ZO-1 in the pedestals or actin tails associates with other structural components that are specifically incorporated within the particular actin-rich structures. Our finding that ZO-1 is recruited to the distal part of the localized F-actin bundles could be a clue to identifying the ZO-1-binding proteins within the structures.
Another approach to understanding the mechanism of ZO-1's recruitment is to search for a common trigger for the formation of particular F-actin bundles that bind with ZO-1. In this study, we demonstrated that three pathogens created ZO-1-associated actin-rich structures, which commonly occur downstream of a WASP-related signaling pathway. To test the notion that the signal is tightly coupled with ZO-1's recruitment, we performed an Nck clustering assay and found that the clustering induced the recruitment of ZO-1 to the actin comets. Thus, the signal appears to be a key to the recruitment. WASP-mediated actin polymerization has been observed in a variety of biological processes, such as the formation of an actin ring at the immunological synapse (2), the growth factor-stimulated changes in cell shape and migration (14, 25), and the vesicle-propelling effect upon overexpression of phosphatidylinositol-4-phosphate 5-kinase (4). Understanding whether ZO-1 is also recruited during these processes and whether ZO-1 is required for these processes is important to differentiate the ZO-1-bound actin-rich structures from the structures without ZO-1.
In conclusion, we have shown that the pathogenic bacteria used in this study recruit ZO-1 to the unique actin-rich structures termed actin tails and pedestals. Although the role of the recruitment in the bacterial pathogenesis is currently unknown, analysis of this phenomenon may unveil a novel role of ZO-1 in the pathological effect of the bacteria. In addition, the recruitment of ZO-1 to the particular F-actin bundles is of great interest, because the mechanism regulating the cellular localization of ZO-1 is largely unknown. Further investigation, using the experimental systems described in this study, will lead to an understanding of the roles of ZO-1 in actin dynamics and of the mechanism regulating the localization of ZO-1 during the reorganization of the cytoskeletal network.
We thank Sho-ichiro Tsukita, Teruhito Yasui, and Bruce J. Mayer for providing DNA constructs and a monoclonal antibody and Kazuko Seto, Teizo Tsukamoto, Junko Matsuyama, and Myonsan Yoh for providing the clinical isolates of S. flexneri and L. monocytogenes. We are also grateful to Sami Fujihara and Kuniko Ishiguro for their technical and secretarial assistance.
Published ahead of print on 21 November 2006. ![]()
Supplemental material for this article may be found at http://iai.asm.org/. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»